K-numberK241637
Device nameEcho Intracranial Base Catheter
ApplicantStryker Neurovascular
Product codeQJP
Device classClass II
Decision dateDec 19, 2024
DecisionSubstantially Equivalent
Regulation870.1250
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Echo Intracranial Base Catheter is a flexible, single-lumen catheter with a 0.100-inch inner diameter designed to facilitate insertion and guidance of interventional devices into the neurovasculature. It features a radiopaque marker band, luer hub, 14 cm lubricious coating on the distal shaft, and is supplied sterile and non-pyrogenic for single use only, packaged with a dilator and two hemostatic valves.

Technological characteristics

The subject device uses a stainless steel hypotube reinforcement (versus stainless steel coil in predicate), has a larger outer diameter of 0.118 inches (predicate 0.109 inches) and inner diameter of 0.100 inches (predicate 0.091 inches), and is offered in longer effective lengths of 100-105 cm (predicate 70-90 cm). Both devices share hydrophilic coating, EO sterilization, single-use supply, and common medical-grade materials, with the subject device including two hemostasis valves versus one in the predicate.

Test standards cited

ISO 10555-1 (catheter mechanical testing), ISO 10993-1, 4, 5, 10, 11, 23 (biocompatibility), EN ISO 14971 (risk management), EN ISO 10993-7 (sterilization residuals), USP <151> (pyrogenicity). The device also underwent simulated use testing in a bench anatomical model and a GLP-compliant subacute animal study in swine vessels.

Substantial equivalence argument

The subject device is substantially equivalent because it shares the same intended use (introduction of interventional devices into neurovasculature), uses identical materials and coating technology, employs the same fundamental operating principles, and demonstrates comparable performance in bench testing (particulate, coating integrity, tip stiffness, frictional force) and animal safety (vessel injury and tissue response comparable to controls). The narrower indication (neurovasculature only versus peripheral, coronary, and neurovasculature in predicate) and design differences (hypotube versus coil, larger dimensions, longer lengths) represent predictable variations that do not alter the fundamental catheter design or safety profile.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →